Toshiba Enters Biochip Market With Novel Chip to Manage Hepatitis C

Oct 18, 2001

NEW YORK, Oct. 18 – Toshiba has entered the biochip arena by developing a DNA chip that it says can help researchers develop individual treatments for patients with hepatitis C, the company said on Thursday.

The company said it planned to start marketing its pilot SNP-detection chip in fiscal 2002, which kicks off in April.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Getting It Early

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

Food Bugs to Meet Sequencers

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

From Ancient Bathrooms

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

This Week in Nature

In Nature this week: ash dieback disease fungal genome, and more.

Main menu